The Icare HOME (TA022) Study: Performance of an Intraocular Pressure Measuring Device for Self-Tonometry by Glaucoma Patients.
Mudie Lucy I, LaBarre Sophie, Varadaraj Varshini, Karakus Sezen, Onnela Jouni, Munoz Beatriz, Friedman David S
AI Summary
This study found that while not all glaucoma patients could use the Icare HOME device, those who could obtained reliable IOP measurements comparable to Goldmann tonometry, offering potential for frequent self-monitoring.
Abstract
Purpose
To evaluate the Icare HOME (TA022) device (Icare Oy, Vanda, Finland) for use by glaucoma patients for self-tonometry.
Design
Prospective performance evaluation of a medical device.
Participants
One hundred eighty-nine participants with glaucoma or suspected glaucoma were recruited from the Wilmer Eye Institute, Baltimore, Maryland, between July 2014 and April 2015.
Methods
Participants had standardized training and had to be able use the Icare HOME device independently. Subjects also had to be able to obtain the first intraocular pressure (IOP) measurement within 5 mmHg of Goldmann applanation tonometry (GAT). Those certified obtained 3 IOP measures using the HOME device, and these were compared with Icare TA01i and GAT IOP measurements.
Main outcome measures
The agreement between Icare HOME and reference tonometers was used to assess precision. The intraclass correlation coefficient was used to assess within-patient reliability for the HOME device.
Results
Eighteen of 189 recruited patients were ineligible to take part in the study. Forty-four of 171 patients (25.7%) started but failed to complete the study: 7 stopped because of time concerns, 10 of 171 patients (6%) stopped because of difficulty using the device during certification, and 27 of 171 patients (16%) failed to be certified based on IOP. The HOME and GAT measurements agreed within 5 mmHg in 116 of 127 participants (91.3%); 2 participants (1.6%) had a difference of more than 7 mmHg. The mean difference between the Icare HOME and GAT measurements was -0.33 mmHg (standard deviation, 3.11 mmHg). The overall intraclass correlation coefficient for the HOME device was 0.92 (95% confidence interval, 0.89-0.95).
Conclusions
Not all participants could learn how to use the Icare HOME device, but for those who could, most were able to obtain measurements similar to those obtained by GAT. The Icare HOME device is safe and reliable for self-tonometry, but nearly 1 in 6 individuals may fail to certify in use of the device based on large differences in IOP when comparing GAT with the Icare HOME measurements. The device has the potential to address an unmet need by providing more frequent IOP measurements in a patient's day to day life.
MeSH Terms
Shields Classification
Key Concepts5
The Icare HOME (TA022) device showed that 116 of 127 participants (91.3%) had intraocular pressure (IOP) measurements that agreed within 5 mmHg with Goldmann applanation tonometry (GAT) measurements.
The mean difference between the Icare HOME (TA022) device and Goldmann applanation tonometry (GAT) measurements was -0.33 mmHg (standard deviation, 3.11 mmHg) in a study evaluating its performance for self-tonometry by glaucoma patients.
The overall intraclass correlation coefficient for the Icare HOME (TA022) device was 0.92 (95% confidence interval, 0.89-0.95) for within-patient reliability in a study of glaucoma patients.
In a study evaluating the Icare HOME (TA022) device, 27 of 171 patients (16%) failed to be certified based on large differences in intraocular pressure (IOP) when comparing Goldmann applanation tonometry (GAT) with Icare HOME measurements.
The Icare HOME (TA022) device is safe and reliable for self-tonometry, but nearly 1 in 6 individuals (16%) may fail to certify in its use due to large differences in intraocular pressure (IOP) compared to Goldmann applanation tonometry (GAT) measurements.
Related Articles5
Development and Evaluation of an Artificial Intelligence Model to Set Target IOP for Glaucoma.
Observational StudyThe relationship between intraocular pressure and glaucoma: An evolving concept.
ReviewLong-term Safety and Performance of a Suprachoroidal Pressure Sensor System: Results of the EYEMATE-SC Trial Follow-up Study.
Clinical TrialGlaucoma Home Self-Testing Using VR Visual Fields and Rebound Tonometry Versus In-Clinic Perimetry and Goldmann Applanation Tonometry: A Pilot Study.
Clinical TrialContinuous 24-hour intraocular pressure monitoring in normal Chinese adults using a novel contact lens sensor system.
Observational StudyIs this article assigned to the wrong chapter(s)? Let us know.